Showing results (691-700 of 1,142) with videos related to
Sort By:
Pageof 115
Journal of Hepatocellular Carcinoma|October 29, 2021
Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological FeaturesAnastasia Murtha-Lemekhova, Juri Fuchs, Erik Schulz, et al.Journal of Hepatocellular Carcinoma|October 31, 2017
Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinomaWaleed Fateen, Farooq Khan, Richard J O'Neill, et al.Journal of Hepatocellular Carcinoma|August 30, 2017
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effectAndrew N de la Torre, Sohail Contractor, Ismael Castaneda, et al.Journal of Hepatocellular Carcinoma|August 31, 2016
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinomaArmeen Mahvash, Ravi Murthy, Bruno C Odisio, et al.Journal of Hepatocellular Carcinoma|August 31, 2016
Transarterial radioembolization for hepatocellular carcinoma: a reviewRodolfo Sacco, Caterina Conte, Emanuele Tumino, et al.Journal of Hepatocellular Carcinoma|April 27, 2017
Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-LMarina G Tarakanovskaya, Jigjidsuren Chinburen, Purev Batchuluun, et al.Journal of Hepatocellular Carcinoma|April 26, 2018
Basic MRI for the liver oncologists and surgeonsLan N Vu, John N Morelli, Janio SzklarukJournal of Hepatocellular Carcinoma|June 19, 2018
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillanceAnna S Griffith, Paul H Hayashi, Lauren Mb Burke, et al.Journal of Hepatocellular Carcinoma|April 22, 2021
A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic ScenarioAngelo Dipasquale, Arianna Marinello, Armando SantoroJournal of Hepatocellular Carcinoma|May 22, 2023
Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical TrialChangcheng Tao, Fan Wu, Hongwei Wang, et al.Pageof 115